Research Article
The 14 bp Del/Ins HLA-G Polymorphism Is Related with High Blood Pressure in Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Table 1
Demographic and clinical assessments in HS, ACS and DM2.
| | HS | DM2 | | Parameter | Average ± SE | | (%) |
| | | | Risk factor | | | Glucose (mg/dL) | | Age (years) | 58±13.09 | | Triglycerides (mg/dL) | | Affected family | 1.25 | | Cholesterol (mg/dL) | | Overweight | 37 (52.85) | | HDL (mg/dL) | | HBP | 34 (48.57) | | LDL (mg/dL) | | Ocular complications | 24 (34.28) | | | | Retinopathy | 12 (17.14) | | | | Treatment | | | | | Glibenclamide | 47 (67.14) | | | | Metformin | 24 (34.28) |
| | ACS | | Parameter | Average ± SE | | (%) |
| | | | Risk factor | | |
Ratio male/female
|
2.74
|
Obesity
|
12 (13.95)
| | Age (years) | | DM2 | 38 (44.19) | | Systolic blood pressure (mmHg) | | DYS | 22 (25.58) | | Diastolic blood pressure (mmHg) | | HBP | 48 (55.81) | | Glucose (mg/dL) | | Smoking | 44 (51.16) | | Triglycerides (mg/dL) | | COPD | 8 (9.3) | | Cholesterol (mg/dL) | | Treatment | | | CK (IU/L) | | AA | 56 (65.12) | | CK-MB (IU/L) | | ACE inhibitors | 54 (62.79) | | Troponin T (ng/mL) | | AnA | 86 (100) | | | | Antidiabetics | 3 (3.49) | | | | ARB | 2 (2.33) | | | | CCB | 10 (11.63) |
|
|
AA: antithrombin agents; ACE: angiotensin converting enzyme; AnA: antiplatelet agents; ARB: angiotensin II receptor blockers; CCB: calcium channel blockers; CK: creatine phosphokinase; CK-MB: creatine phosphokinase MB; COPD: chronic obstructive pulmonary disease; DYS: dyslipidemia; HBP: high blood pressure; HDL: high density lipoprotein; LDL: low density lipoprotein; LLA: lipid lowering agents; SE: standard error.
|
